We report a young female patient with recurrent lupus erythematosus profundus (LEP) who has successfully maintained remission of LEP with cyclosporin A (CsA), although conventional treatments such as systemic corticosteroids (low-dose), dapsone, and other immunosuppressive drugs (azathiopurine, cyclophosphamide) could not maintain remission.
Mascaro JM , Herrero C , Hausmann G . Uncommon cutaneous manifestations of lupus erythematosus . Lupus1997;6: 122–131 .
2.
Winkelmann RK.Panniculitis and systemic lupus erythematosus . JAMA1970;221: 472–475 .
3.
Yamada Y , Dekio S , Jidoi J , Ozasa S . Lupus erythematosus profundus:report of a case treated with dapsone . J Dermatol1989;16: 379–382 .
4.
Royle G , Blacklock H , Miller M . Treatment of cytophagic histiocytic panniculitis with Cyclosporine A . Am J Med1992;92: 704–705 .
5.
Usuki K , Kitamura K , Urabe A , Takaku F . Successful treatment of Weber-Christian disease by cyclosporine A . Am J Med1988;85: 276–278 .
6.
Fruman DA , Klee CB , Biever BE , Burakoff SJ . Calcineurin phaphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A . Proc Natl Acad Sci USA1990;89: 3686–3690 .
7.
Hytiroglou P , Phelps RG , Wattenberg DJ , Strauchen JA . Cytophagic histiocytic panniculitis;Molecular evidence for a clonal T cell disorder . J Am Acad Dermatol, 1992;27: 333–336 .
